[Federal Register Volume 71, Number 162 (Tuesday, August 22, 2006)]
[Notices]
[Page 48948]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E6-13848]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated April 17, 2006, and published in the Federal 
Register on April 21, 2006, (71 FR 20729), Guilford Pharmaceuticals, 
Inc., 6611 Tributary Street, Baltimore, MD 21224, made application by 
renewal to the Drug Enforcement Administration (DEA) to be registered 
as a bulk manufacturer of Cocaine (9041), a basic class of controlled 
substance listed in Schedule II.
    The company plans to manufacture a cocaine derivative to be used in 
clinical research studies.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Guilford Pharmaceuticals, Inc. to manufacture the listed basic classes 
of controlled substances is consistent with the public interest at this 
time. DEA has investigated Guilford Pharmaceuticals, Inc. to ensure 
that the company's registration is consistent with the public interest. 
The investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with State and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 
21 CFR 1301.33, the above named company is granted registration as a 
bulk manufacturer of the basic classes of controlled substances listed.

    Dated: August 15, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E6-13848 Filed 8-21-06; 8:45 am]
BILLING CODE 4410-09-P